About MESA

MESA İlaç ve Sağlık Ürünleri began as a sole proprietorship in 2013, later re-established as a limited company in 2023.

But its story starts earlier than that — in the years of experience that shaped why it needed to exist at all.

Mahmut Sayım's career in healthcare began at Toprak İlaç. Over the years that followed, he moved through nearly every side of the pharmaceutical business — sales, field operations, product and marketing, and close working relationships with healthcare professionals.

Later in his career, he also gained experience in distribution — a view of the industry built from nearly every angle, long before MESA existed.

That experience became the foundation for something he wanted to build for himself: his own products, and his own brands.

SEOXIN marks one of the earliest stages of that journey — the first brand to carry Mahmut Sayım's growing ambition to build something independent.

Its trademark was registered on 4 May 2006, the earliest verified milestone in MESA's history.

SEOXIN was developed alongside Farmasea, Mahmut Sayım's first venture built through a business partnership — an important step in moving from industry experience toward building brands of his own.

In time, that partnership structure proved unsustainable. The brands built during this period were carried forward independently, laying the groundwork for a more independent company to come.

Farmasea represents a formative stage in MESA's story: the transition between working within the industry and building something independent within it.

STREPDOPS followed, its trademark registered on 27 May 2008 — another verified milestone on the road toward an independent company.

That road led to 2013, when MESA İlaç ve Sağlık Ürünleri was established as a sole proprietorship. Its purpose was simple and specific: to create proprietary healthcare products, and to build brands of its own.

The name itself carries a personal note — MESA is derived from the initials of Melek Sayım. But the story that matters here is one of purpose, not sentiment: a company built to develop its own brands, independently.

Canberk Sayım's involvement with MESA began earlier than 2018 — he was already part of the company during his high-school years. In 2018, after completing his two-year degree at Arel University, he joined full-time.

His early focus was foundational: updating product packaging, improving product content, and establishing a consistent identity across MESA's brands.

From there, his responsibilities grew to include product development, brand development, customer experience and digital transformation — alongside field operations, an area MESA is still early in developing.

Today, MESA is active in food supplements and cosmetics — developing and growing brands of its own.

The focus remains on building premium healthcare brands, with product development and brand development as the company's core ongoing work.

MESA's long-term ambition is to build stronger proprietary brands, and to grow beyond where it stands today.

International expansion is part of that ambition — a future MESA is working toward, not yet a place it operates.